歡迎來到上海通蔚!

021-54845833/15800441009

品質(zhì)保證 · 通蔚試劑

當(dāng)前位置: 首頁 > 科研產(chǎn)品 > 科研抗體 > 一抗 > 兔抗CD274多克隆抗體

產(chǎn)品中心

  • 兔抗CD274多克隆抗體

    規(guī)格:
    數(shù)量:

    購買數(shù)量

    價(jià)格:
    • 品牌 : 通蔚生物
    • 目錄號 : TW5162
    • 應(yīng)用 : 僅用于科研使用
    • 保存條件 : 低溫保存
    • 貨期 : 現(xiàn)貨
    • 商品庫存:35
  • 商品詳情
  • 參考文獻(xiàn)
  • 說明書下載
  • 商品評論0
  • 相關(guān)產(chǎn)品

中文名稱:兔抗CD274多克隆抗體

英文名稱:
Anti-CD274 rabbit polyclonal antibody

抗      原: CD274

別      名: B7-H; B7H1; PDL1; PD-L1; PDCD1L1; PDCD1LG1

儲      存: 冷凍(-20℃)

宿      主: Rabbit

相關(guān)類別: 一抗

反應(yīng)種屬: Human, Mouse

標(biāo) 記 物: Unconjugate

克隆類型:
rabbit polyclonal

技術(shù)規(guī)格

Background:

This gene encodes an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. The encoded protein is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human malignancies, including colon cancer and renal cell carcinoma. Alternative splicing results in multiple transcript variants.

Applications:

ELISA, WB, IHC

Name of antibody:

CD274

Immunogen:

Synthetic peptide of human CD274

Full name:

CD274 molecule

Synonyms:

B7-H; B7H1; PDL1; PD-L1; PDCD1L1; PDCD1LG1

SwissProt:

Q9NZQ7

ELISA Recommended dilution:

5000-10000

IHC positive control:

Human esophagus cancer and Human liver cancer

IHC Recommend dilution:

40-200

WB Predicted band size:

33 kDa

WB Positive control:

A549,Raji,RAW264.7,Jurkat and HepG2 cell lysates

WB Recommended dilution:

200-1000